Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DART Registry: Diagnosing Adverse Drug Reactions Registry

NCT01970709 is registered in ClinicalTrials.gov with Renaissance RX as lead sponsor.

NCT NCT01970709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01970709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DART Registry: Diagnosing Adverse Drug Reactions Registry
Lead sponsor
Renaissance RX
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2013
Completion date
Not reported
Enrollment
250,000 (estimated)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

genetics of drug metabolism